Views & analysis - Pharmaphorum

Trending

Latest Views & analysis

in Views & Analysis
Chinese pharma market primed for growth after sweeping reforms
September 25, 2018 Share
X
Chinese pharma market primed for growth after sweeping reforms
https://pharmaphorum.com/r-d/views-analysis-r-d/chinese-pharma-market/
in Views & Analysis
A global outlook: government affairs and policy
September 24, 2018 Share
X
A global outlook: government affairs and policy
https://pharmaphorum.com/views-analysis-patients/a-global-outlook-government-affairs-and-policy/
in Views & Analysis
Digital news round-up: AZ taps into China with robots, and ECG app wars
September 21, 2018 Share
X
Digital news round-up: AZ taps into China with robots, and ECG app wars
https://pharmaphorum.com/views-analysis-digital/astrazeneca-taps-into-china-with-robots-and-ecg-app-wars/
in Views & Analysis
Raising awareness about rare diseases
September 20, 2018 Share
X
Raising awareness about rare diseases
https://pharmaphorum.com/views-analysis-patients/awareness-rare-diseases/

Digital news round-up: AZ taps into China with robots, and ECG app wars

Digital news round-up: AZ taps into China with robots, and ECG app wars

Richard Staines presents his weekly round-up of the latest digital health stories

X

Digital news round-up: AZ taps into China with robots, and ECG app wars

https://pharmaphorum.com/views-analysis-digital/astrazeneca-taps-into-china-with-robots-and-ecg-app-wars/

Raising awareness about rare diseases

Raising awareness about rare diseases

A family tragedy has prompted Kay Parkinson, founder of the rare disease charity Alstrom Syndrome UK, to create

X

Raising awareness about rare diseases

https://pharmaphorum.com/views-analysis-patients/awareness-rare-diseases/

How people power is building patient-centric pharma

How people power is building patient-centric pharma

While everyone is agreed on the importance of patient-centric pharma, just one fifth of industry insiders said they

X

How people power is building patient-centric pharma

https://pharmaphorum.com/views-analysis-patients/how-people-power-is-building-patient-centric-pharma/

Recommended authors

More Views & Analysis

Nimble consumer healthcare innovation: the pharmaphorum podcast

Nimble consumer healthcare innovation: the pharmaphorum podcast

In episode 2 of the podcast pharmaphorum talked to the CEO of Infirst Healthcare Manfred Scheske about how

X

Nimble consumer healthcare innovation: the pharmaphorum podcast

https://pharmaphorum.com/views-analysis-sales-marketing/consumer-healthcare-innovation/

Finding the roadmap for living with LHON

Finding the roadmap for living with LHON

Every patient faces their own journey through life, learning about their condition with the best tools available to

X

Finding the roadmap for living with LHON

https://pharmaphorum.com/disease-spotlight/finding-the-roadmap-living-with-lhon/

Digital health round-up: Akili, NVIDIA, Hu-manity.co and more

Digital health round-up: Akili, NVIDIA, Hu-manity.co and more

In this week’s pharmaphorum digital health round-up we look at Akili’s therapeutic video game, the unveiling of next-gen

X

Digital health round-up: Akili, NVIDIA, Hu-manity.co and more

https://pharmaphorum.com/views-and-analysis/digital-health-akili-nvidia-humanityco-wannacry/

What next for joint working that really improves patient outcomes?

What next for joint working that really improves patient outcomes?

Joint working has become something of the norm in the last decade, but have we taken the time

X

What next for joint working that really improves patient outcomes?

https://pharmaphorum.com/views-analysis-patients/what-next-joint-working-improves-patient-outcomes/

Taking on the challenge of childhood epilepsy

Taking on the challenge of childhood epilepsy

Japan’s Eisai has a long-term commitment to treating epilepsy, with a series of therapies already on the market

X

Taking on the challenge of childhood epilepsy

https://pharmaphorum.com/r-d/views-analysis-r-d/taking-challenge-childhood-epilepsy/

Balancing the sySTEM

Balancing the sySTEM

A group of pharma companies – Amgen, AstraZeneca and GlaxoSmithKline – have partnered with the UK government’s Equalities

X

Balancing the sySTEM

https://pharmaphorum.com/r-d/views-analysis-r-d/balancing-the-system/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com